Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis

OBJECTIVES: To assess cost-effectiveness of direct oral anticoagulants (DOACs) compared with vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF) by pooling incremental net benefits (INBs). DESIGN: Systematic review and meta-analysis. SETTING: We searched PubMed, Scopus and...

Descripción completa

Detalles Bibliográficos
Autores principales: Noviyani, Rini, Youngkong, Sitaporn, Nathisuwan, Surakit, Bagepally, Bhavani Shankara, Chaikledkaew, Usa, Chaiyakunapruk, Nathorn, McKay, Gareth, Sritara, Piyamitr, Attia, John, Thakkinstian, Ammarin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Evidence Synthesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340051/
https://www.ncbi.nlm.nih.gov/pubmed/34635480
http://dx.doi.org/10.1136/bmjebm-2020-111634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340051/
https://www.ncbi.nlm.nih.gov/pubmed/34635480
http://dx.doi.org/10.1136/bmjebm-2020-111634

Ejemplares similares